A
Acrivon Therapeutics, Inc. (ACRV)
NGM – Real vaqt narxi. Valyuta: USD
1.89
-0.02 (-1.05%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
1.89
-0.02 (-1.05%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Acrivon Therapeutics, Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, o'zining generativ fosfoproteomika platformasidan foydalangan holda, har bir dori vositasiga sezgir bo'lishi bashorat qilingan bemorlar uchun onkologik dorilarni kashf qiladi va ishlab chiqadi. Kompaniya Acrivon Predictive Precision Proteomics (AP3) platformasini boshqaradi, bu platforma dori vositalariga xos bo'lgan patentlangan OncoSignature hamroh diagnostikasini yaratishga imkon beradi, ular o'zining dorilari nomzodlaridan foyda ko'radigan bemorlarni aniqlash uchun ishlatiladi. Uning asosiy klinik nomzodi ACR-368 bo'lib, bu CHK1 va CHK2 ni maqsad qilgan selektiv kichik molekulali ingibitordir, u endometrium va platina-chidamli tuxumdon saratoni, shuningdek, SCClar, masalan, SCCHN va anal saratoni bilan og'rigan bemorlarni davolash uchun mo'ljallangan. Kompaniya, shuningdek, ACR-2316, dual WEE1 va PKMYT1 ingibitori bo'lgan kichik molekulali nomzodni; va AP3 va ko'kristallografiyaga asoslangan klinikgacha bo'lgan hujayra sikli dasturini ishlab chiqmoqda. Kompaniya 2018 yilda tashkil etilgan va Votertaun, Massachusetsda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Adam D. Levy M.B.A., Ph.D. | CFO & Principal Financial Officer |
| Dr. Eric J. Devroe Ph.D. | Chief Operating Officer |
| Dr. Erick Gamelin M.D., Ph.D. | Chief Development Officer |
| Dr. Jesper V. Olsen Ph.D. | Academic Co-Founder, Head of Phosphoproteomics & Member of Scientific Advisory Board |
| Dr. Peter Blume-Jensen M.D., Ph.D. | Co-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer |
| Mr. Bruce Close | Vice President of Quality & Compliance |
| Mr. Joon Jung Ph.D. | VP & Head of Data Science |
| Ms. Katharine Peterson CPA | Vice President of Finance & Accounting |
| Ms. Kristina Masson M.B.A., Ph.D. | Co-Founder, Executive VP of Business Operations, Site Head, Treasurer & Director |
| Ms. Mary-Alice Miller J.D. | Chief Legal Officer & Corporate Secretary |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-30 | DEFA14A | acrv-20260428.htm |
| 2026-04-30 | DEF 14A | acrv-20260430.htm |
| 2026-03-19 | S-8 | d390264ds8.htm |
| 2026-03-19 | 10-K | acrv-20251231.htm |
| 2026-03-02 | 8-K | d111455d8k.htm |
| 2026-02-27 | 8-K | d116670d8k.htm |
| 2026-01-08 | 8-K | acrv-20260108.htm |
| 2025-11-13 | 10-Q | acrv-20250930.htm |
| 2025-09-05 | 8-K | acrv-20250905.htm |
| 2025-08-13 | 8-K | acrv-20250813.htm |